Treating an arteriosclerosis with glimepiride

Details Treating an arteriosclerosis with glimepiride Treating an arteriosclerosis with glimepiride

1993-12-23

1995-05-16

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514824, A61K 31095, A61K 3140

Patent

active

054161053

ABSTRACT:
A pharmaceutical composition containing as an active ingredient glimepiride. The composition is used for preventing or treating arteriosclerosis with no influence on lipid metabolism and no increase in plasma insulin level.

REFERENCES:
patent: 4379785 (1983-04-01), Weyer et al.
patent: 4411903 (1983-10-01), Shepherd
patent: 5082856 (1992-01-01), Taniguchi et al.
Y. Ozaki et al., "Effects of Oral Hypoglycaemic Agents on Platelet Functions", Biochemical Pharmacology, vol. 44, No. 4, pp. 687-691, 1992.
M. Omosu et al., "Effects of Hoe 490, A New Oral Antidiabetic Agent, on Platelet Aggregation", Japan J. Pharmacol., vol. 49, p. 328P, 1989.
Z. Aranyi, "Clinical and Experimental Comparison of the Cardiovascular Effects of Glibenclamide, Glimepiride and Gliclazide in Diabetes", vol. 24, Supplement I, p. S228, 1992.
G. Marquie, "Effects Preventifs du Gliclazide sur le Developpement de l'atherosclerose induite par le cholesterol chez le Lapin", C. R. Acad. Sc. Paris, Serie D, vol. 285, pp. 197-200, Jul. 11, 1977.

Affiliated with

Also associated with

Rating

Treating an arteriosclerosis with glimepiride does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating an arteriosclerosis with glimepiride, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating an arteriosclerosis with glimepiride will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-637985